Literature DB >> 17689503

Promoter analysis of human glutamate carboxypeptidase II.

Liqun Han1, Dona Lee Wong, Guochuan Tsai, Zhichun Jiang, Joseph T Coyle.   

Abstract

The expression of glutamate carboxypeptidase II (GCP II) is reduced in selective brain regions in schizophrenic patients. To investigate transcriptional mechanisms regulating the human GCP II gene, a 3460 bp DNA fragment comprised of the proximal 3228 bp of 5' untranscribed sequence and first 232 bp of 5' UTR portion of this gene was cloned into the mammalian luciferase reporter gene vector pGL3-Basic. Transfection assays in human astrocyte-derived SVG and human prostate tumor-derived LNCaP cells demonstrated that constructs with 3460, 1590 and 761 bp portions of 5' region of human GCP II gene were able to drive the luciferase reporter gene. Additional deletion constructs showed that in the SVG cell line, constructs with 511 and 411 bp of GCP II gene fragments yielded highest transcriptional activity, with declining activity upon further removal of 5' sequences. 15 bp of the promoter 5' to a 225 bp GCP II fragment were essential for luciferase expression. Thus, in the SVG cells, the proximal 240 bp of the human GCP II promoter (232 bp of the 5' UTR and 8 bp of 5' untranscribed sequences) may represent the core promoter. Further, while a LyF-1 site lies within and overlaps a transcription start site in the 15 bp sequence, site-directed mutagenesis shows that LyF-1 is not the transcription initiator for the "TATA and CAAT" box lacking GCP II gene in the SVG cells. Finally, pattern differences in GCP II gene promoter expression in SVG and LNCaP cells suggest that sequences beyond 240 bp may be important for tissue-specific GCP II expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17689503      PMCID: PMC2706136          DOI: 10.1016/j.brainres.2007.07.017

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  40 in total

1.  A tissue-specific enhancer of the prostate-specific membrane antigen gene, FOLH1.

Authors:  F Watt; A Martorana; D E Brookes; T Ho; E Kingsley; D S O'Keefe; P J Russell; W D Heston; P L Molloy
Journal:  Genomics       Date:  2001-05-01       Impact factor: 5.736

2.  Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system.

Authors:  U V Berger; R Luthi-Carter; L A Passani; S Elkabes; I Black; C Konradi; J T Coyle
Journal:  J Comp Neurol       Date:  1999-12-06       Impact factor: 3.215

3.  Upregulation of prostate specific membrane antigen/folate hydrolase transcription by an enhancer.

Authors:  Kenneth R Noss; Steven A Wolfe; Sidney R Grimes
Journal:  Gene       Date:  2002-02-20       Impact factor: 3.688

4.  Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia.

Authors:  Y Hakak; J R Walker; C Li; W H Wong; K L Davis; J D Buxbaum; V Haroutunian; A A Fienberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

5.  Preliminary study of immunomagnetic quantification of circulating tumor cells in patients with advanced disease.

Authors:  B T Chen; R D Loberg; C K Neeley; S M O'Hara; S Gross; G Doyle; R L Dunn; L M Kalikin; K J Pienta
Journal:  Urology       Date:  2005-03       Impact factor: 2.649

6.  Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase.

Authors:  D J Bacich; J T Pinto; W P Tong; W D Heston
Journal:  Mamm Genome       Date:  2001-02       Impact factor: 2.957

7.  Molecular staging by RT-pCR analysis for PSA and PSMA in peripheral blood and bone marrow samples is an independent predictor of time to biochemical failure following radical prostatectomy for clinically localized prostate cancer.

Authors:  Constantine S Mitsiades; Peter Lembessis; Antigone Sourla; Constantine Milathianakis; Athanassios Tsintavis; Michael Koutsilieris
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

8.  Structure and promoter activity of the human glia maturation factor-gamma gene: a TATA-less, GC-rich and bidirectional promoter.

Authors:  Yoko Kawai; Kiyofumi Asai; Yutaka Miura; Yuichiro Inoue; Manami Yamamoto; Akihiko Moriyama; Naoki Yamamoto; Taiji Kato
Journal:  Biochim Biophys Acta       Date:  2003-02-20

9.  NAAG reduces NMDA receptor current in CA1 hippocampal pyramidal neurons of acute slices and dissociated neurons.

Authors:  Richard Bergeron; Joseph T Coyle; Guochan Tsai; Robert W Greene
Journal:  Neuropsychopharmacology       Date:  2005-01       Impact factor: 7.853

10.  Regulation of transcription of the murine gamma-glutamyl hydrolase gene. Delineation of core promoter A and the role of LYF-1, E2F and ETS-1 in determining tumor-specific expression.

Authors:  Naoko Masumoto; Jing Chen; F M Sirotnak
Journal:  Gene       Date:  2002-05-29       Impact factor: 3.688

View more
  3 in total

1.  Interferon stimulated exonuclease gene 20 kDa links psychiatric events to distinct hepatitis C virus responses in human immunodeficiency virus positive patients.

Authors:  Antonios Katsounas; Joseph J Rasimas; Joerg F Schlaak; Richard A Lempicki; Donald L Rosenstein; Shyam Kottilil
Journal:  J Med Virol       Date:  2014-04-30       Impact factor: 2.327

2.  Narcoleptic orexin receptor knockout mice express enhanced cholinergic properties in laterodorsal tegmental neurons.

Authors:  M Kalogiannis; S L Grupke; P E Potter; J G Edwards; R M Chemelli; Y Y Kisanuki; M Yanagisawa; C S Leonard
Journal:  Eur J Neurosci       Date:  2010-06-22       Impact factor: 3.386

3.  Microarrays-Enabled Hypothesis Generation: The Suspect Role of FNBP-1 in Neuropsychiatric Pathogenesis Associated with HIV and/or HCV Infection.

Authors:  A Katsounas; K R Wilting; R A Lempicki; J F Schlaak; G Gerken
Journal:  J AIDS Clin Res       Date:  2016-12-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.